Don’t miss the latest developments in business and finance.

Ipca Laboratories acquires High Potency Oral Solid Dosage formulations manufacturing unit

Image
Capital Market
Last Updated : Oct 01 2014 | 5:01 PM IST

Located at Pithampur in Madhya Pradesh.

Ipca Laboratories announced that the Company has acquired as a going concern on slump sale basis the High Potency Oral Solid Dosage formulations manufacturing unit situated at Pithampur in Madhya Pradesh.

This manufacturing unit has the approval of the WHO-GMP and INVIMA Colombai and was also recently inspected by German Regulatory Agency and their approval is pending.

This acquisition will help the Company in forward integrating the hormonal APIs being manufactured by the Company at its manufacturing unit situated at Nandesari with hormonal formulation for the world markets.

Powered by Capital Market - Live News

More From This Section

First Published: Oct 01 2014 | 4:23 PM IST

Next Story